ExoStem is a stem cell-derived exosome product featuring purified protein vesicles from mesenchymal stem cells of newborn umbilical cord tissue. It contains numerous growth factors to regulate cellular and biochemical events in skin rejuvenation, tissue regeneration, and cell repair.

StemBiocell provides cGMP-compliant production and banking of cellular therapy products. The division manages mesenchymal stem cells, hematopoietic stem cells, immunotherapy products, tissue engineering cellular products, and stromal cellular products with continuous traceability from raw tissue supply to the end-user delivery.

Stemcord offers autologous and allogeneic cord blood and cord tissue banking. It collects, processes, and cryptopreserves hematopoietic (blood-forming) and mesenchymal stem cells from newborn umbilical cords under cGMP and cGTP standards to provide a long-term bio-insurance resource for families.